Glycans in Drug Design
Glycans are elements of numerous bio-therapeutic mediators, ranging from natural products to molecules based on rational plan to recombinant glycoproteins. The glycan components of these agents can be important aspects of their biological activity and therapeutic efficacy. Biochemistry and Glycobiology includes a multidisciplinary study of carbohydrate-binding proteins (lectins), glycolipids and some selected other plant proteins that are skilful of connecting with endogenous or foreign (macro) molecules. The eminence of the research is on protein-carbohydrate interaction and their involvement in signalling procedures in plants or in plant protection. Based on the formed fundamental alertness new methods are being industrialised to shield crop plants against pests and diseases.
- Membrane biophysics
- Systems Biology
- Enzyme synthesis
- Biophysical approaches to cell biology
- Computational and theoretical Biophysics
Related Conference of Glycans in Drug Design
Glycans in Drug Design Conference Speakers
Recommended Sessions
Related Journals
Are you interested in
- Advanced Biofuels and Sustainable Fuel Technologies - Biodiesel 2027 (France)
- Algae-Based Biofuels and Marine Bioenergy - Biodiesel 2027 (France)
- Biogas, Biomethane and Anaerobic Digestion - Biodiesel 2027 (France)
- Biohydrogen and Hydrogen Production from Biomass - Biodiesel 2027 (France)
- Biomass Conversion and Bioenergy Technologies - Biodiesel 2027 (France)
- Biorefineries and Integrated Biomass Processing - Biodiesel 2027 (France)
- Lignocellulosic Biomass and Cellulosic Biofuels - Biodiesel 2027 (France)
- Pyrolysis, Gasification and Hydrothermal Conversion - Biodiesel 2027 (France)
- Sustainable Aviation Fuels and Renewable Transportation - Biodiesel 2027 (France)
- Sustainable Biomass Feedstocks and Supply Chains - Biodiesel 2027 (France)

